AS-35

    WARNING: This product is for research use only, not for human or veterinary use.

Hodoodo CAT#: H524264

CAS#: 108427-72-1

Description: AS 35 is an antiallergic drug. AS-35 controls allergic diseases by inhibiting eosinophil activation.


Chemical Structure

img
AS-35
CAS# 108427-72-1

Theoretical Analysis

Hodoodo Cat#: H524264
Name: AS-35
CAS#: 108427-72-1
Chemical Formula: C21H20N6O4
Exact Mass: 420.15
Molecular Weight: 420.420
Elemental Analysis: C, 59.99; H, 4.79; N, 19.99; O, 15.22

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: AS 35; AS35; AS-35;

IUPAC/Chemical Name: 4H-Pyrido(1,2-a)pyrimidin-4-one, 9-((4-acetyl-3-hydroxy-2-propylphenoxy)methyl)-3-(1H-tetrazol-5-yl)-

InChi Key: RVRGDCZGEKSIRW-UHFFFAOYSA-N

InChi Code: InChI=1S/C21H20N6O4/c1-3-5-15-17(8-7-14(12(2)28)18(15)29)31-11-13-6-4-9-27-20(13)22-10-16(21(27)30)19-23-25-26-24-19/h4,6-10,29H,3,5,11H2,1-2H3,(H,23,24,25,26)

SMILES Code: c12ncc(c(n1cccc2COc1c(c(c(cc1)C(=O)C)O)CCC)=O)c1nnn[nH]1

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO, not in water

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 420.42 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Kozloski GD, De Vito JM, Johnson JB, Holmes GB, Adams MA, Hunt TL. Bioequivalence of verapamil hydrochloride extended-release pellet-filled capsules when opened and sprinkled on food and when swallowed intact. Clin Pharm. 1992 Jun;11(6):539-42. PubMed PMID: 1600686. 1: Khan P, Saxena T, Adarsh KV. Tailoring between network rigidity and nanosecond transient absorption in a-Ge(x)As(35-x)Se₆₅ thin films. Opt Lett. 2015 Mar 1;40(5):768-71. doi: 10.1364/OL.40.000768. PubMed PMID: 25723428.

2: Khan P, Jain H, Adarsh KV. Role of Ge:As ratio in controlling the light-induced response of a-Ge(x)As(35-x)Se65 thin films. Sci Rep. 2014 Feb 7;4:4029. doi: 10.1038/srep04029. PubMed PMID: 24504158; PubMed Central PMCID: PMC3916963.

3: van Leeuwen R, Chakravarthy U, Vingerling JR, Brussee C, Hooghart AJ, Mulder PG, de Jong PT. Grading of age-related maculopathy for epidemiological studies: is digital imaging as good as 35-mm film? Ophthalmology. 2003 Aug;110(8):1540-4. PubMed PMID: 12917169.

4: Hamasaki Y, Zaitu M, Tsuji K, Miyazaki M, Hayasaki R, Muro E, Yamamoto S, Kobayashi I, Matsuo M, Ichimaru T, Miyazaki S. (9-[4-acetyl-3-hydroxy-2-n-propylphenoxy) methyl]-3-(1H-tetrazol-5-yl)-4H-pyrido [1,2-a] pyrimidin-4-one), AS-35, inhibits leukotriene synthesis. Int J Immunopharmacol. 2000 Jul;22(7):483-90. PubMed PMID: 10785545.

5: Owens DR, Gibbins RL, Lewis PA, Wall S, Allen JC, Morton R. Screening for diabetic retinopathy by general practitioners: ophthalmoscopy or retinal photography as 35 mm colour transparencies? Diabet Med. 1998 Feb;15(2):170-5. PubMed PMID: 9507921.

6: Kawashima T, Nagaki S, Iwakaji A, Iwamoto I, Yoshida S, Tomioka H. [Inhibitory effect of AS-35. a novel antiallergic drug, on chemical mediator release from human eosinophils]. Arerugi. 1994 Dec;43(11):1326-30. Japanese. PubMed PMID: 7887808.

7: Takata H, Tamura G, Shibasaki A, Honma M, Takishima T. [Effect of AS-35 aerosol on bronchoconstriction induced by specific antigens in macacus rhesus monkeys]. Arerugi. 1993 Jul;42(7):870-7. Japanese. PubMed PMID: 7689825.

8: Watanabe-Kohno S, Yasui K, Ohkawa E, Yamamura H, Horiba M, Inoue K, Ohata K. Effect of AS-35 on agonist-induced contractions and the resting tonus of airway smooth muscles and the in vitro release of chemical mediators from passively sensitized lung fragments from humans and guinea pigs. Jpn J Pharmacol. 1992 Jun;59(2):227-33. PubMed PMID: 1279252.

9: Kasai H, Yanagihara Y. Inhibition of radiolabeled leukotriene-binding by AS-35 in guinea pig lung membrane fraction. Jpn J Pharmacol. 1992 Apr;58(4):357-64. PubMed PMID: 1405033.

10: Kasai H, Kawashima T, Omura S, Yanagihara Y. Peptide leukotriene antagonistic activity of AS-35, a new antiallergic drug. Jpn J Pharmacol. 1992 Apr;58(4):347-55. PubMed PMID: 1405032.

2: Christrup LL, Bonde J, Rasmussen SN, Rassing MR. Relative bioavailability of (+/-)-verapamil hydrochloride administered in tablets and chewing gum. Acta Pharm Nord. 1990;2(6):371-6. PubMed PMID: 2095796. 3: Marvola M, Kannikoski A, Taskinen J, Ottoila P. Assessment of bioavailability of experimental single-unit sustained release tablets of verapamil hydrochloride using the stable isotope technique. J Pharm Pharmacol. 1985 Nov;37(11):766-70. PubMed PMID: 2867156.